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1226 The Journal of Thoracic and CardObjective: The aim of this study was to evaluate the efficacy of the objective
radiologic analysis of high-resolution computed tomographic images of small pe-
ripheral non–small cell lung cancer and to select the candidates for curative limited
resection.
Methods: High-resolution computed tomographic images of 146 surgically resected
T1 N0 M0 peripheral non–small cell lung cancers were analyzed by using National
Institutes of Health image software and classified on the basis of the percentage of
ground-glass opacity within the tumor.
Results: Eighty-seven percent of tumors with ground-glass opacity ratios of 90% to
100% (type I) were diagnosed as noninvasive bronchioloalveolar carcinoma, whereas
55.6% of tumors with ground-glass opacity ratios of 50% to 89% (type II) consisted of
adenocarcinoma. Tumors with ground-glass opacity ratios of 50% or more (type I/II)
had no nodal involvement, whereas nodal metastases were identified in 20.0% of tumors
with ground-glass opacity ratios of 10% to 49% (type III) and 24.4% of tumors with
ground-glass opacity ratios of less than 10% (type IV). No tumors with ground-glass
opacity ratios of 50% or more showed vessel infiltration, except for one lesion with a
ground-glass opacity ratio of 50%. The 3-year disease-free survival was 97.7% for type
I/II, 86.1% for type III, and 78.5% for type IV tumors.
Conclusions: The objective quantitative radiologic analysis with National Institutes
of Health image software exhibited a good correlation with the histologic classifi-
cation, pathologic invasiveness, and postoperative outcome of small peripheral lung
cancer. Patients with tumors that have ground-glass opacity ratios of greater than
50% are considered to be possible candidates for limited pulmonary resection.
With recent advances in low-dose helical computed tomography (CT), thedetection of small peripheral lung cancer has been notably increasing.1-5 Amajority of the CT-detected lung cancers are adenocarcinomas, which often
show ground-glass opacity (GGO) on a high-resolution CT (HRCT) image. GGO is
caused by alveolar lining tumor growth with an increase in the thickness of the alveolar
septa, and it corresponds to the bronchioloalveolar carcinoma (BAC) component of the
tumor.6 Several previous studies reported that the percentage of GGO area within a
tumor was a prognostic factor in peripheral lung adenocarcinoma.7-9 These reports
iovascular Surgery ● June 2005
Nakata et al General Thoracic Surgery
G
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in the maximum dimension on HRCT image were minimal or
no invasive adenocarcinomas, which exhibited an excellent
postoperative outcome. Although the results suggested that
tumors with large GGO ratios could be likely candidates for
limited pulmonary resection for cure, the adequate criteria for
selecting patients for limited resection are still controversial.
One of the reasons for the controversy is limited objectivity in
the radiologic evaluation of the GGO ratio. Although GGO is
defined as hazy increased attenuation of the lung without
obscuration of the underlying vascular markings,10 most of the
previous studies were based on the results of the macroscopic
measurement of the GGO ratio on HRCT imaging. Unless an
objective method to measure the GGO percentage is estab-
lished, the results are different among individuals, and the
liberal application of limited pulmonary resection might result
in an increased risk of local or early recurrences. In this study
we used National Institutes of Health (NIH) image software to
establish an objective radiologic analysis of small peripheral
lung cancer. NIH image software is a public domain, image-
processing, and objective analysis program developed at the
NIH in the United States. The aim of this study was to evaluate
the efficacy of the objective radiologic analysis with NIH
image software and to select the appropriate candidates for
limited resection among the patients with small peripheral
non–small cell lung cancer (NSCLC).
Patients and Methods
Patients
From January 1999 through December 2001, 280 patients with
Figure 1. A, An HRCT image of small peripheral adenoc
was transformed into 20 optional colors according to
calculated by tracing the colors corresponding to theNSCLC underwent pulmonary resection at National Shikoku
The Journal of ThoracicCancer Center. Of these, 146 patients were classified as having
clinical stage IA peripheral-type lung cancer. Staging proce-
dures included HRCT of the chest, ultrasonography of the upper
abdomen, magnetic resonance imaging of the brain, and bone
scintigraphy. Lymph nodes smaller than 10 mm along the short
axis on the CT scan were defined as negative nodes. Preoper-
ative analyses of the HRCT images were performed with NIH
image software for these 146 consecutive patients. The subjects
included 68 men and 78 women with a median age of 64.9 years
(range, 38-87 years). Surgical procedures were selected on the
basis of the performance status, pulmonary function, and HRCT
findings of the lesions. As described in our previous report,11
limited resection was adopted prospectively for tumors with a
pure GGO appearance on HRCT since June 2000. The surgical
procedures performed were as follows: lobectomy with sys-
temic mediastinal dissection in 103 patients, segmentectomy
with hilar sampling in 7 patients, and wedge resection in 36
patients. Histologic diagnoses were made according to the
recent World Health Organization histologic classification.12
The histologic type was BAC in 44 patients, adenocarcinoma in
87 patients, squamous cell carcinoma in 13 patients, and large
cell carcinoma in 2 patients.
Radiologic Analysis With NIH Image Software
CT scanning was performed on a Somatom Plus 4 (Siemens
Medical Systems, Malvern, Pa), and the images were photo-
graphed by using a window level of 500 Hounsfield units and a
window width of 1500 Hounsfield units. The lesions were subject
to scanning with 2-mm–thick sections at one breath hold. Preop-
erative analyses with NIH image software were performed on the
HRCT image at the maximum dimension of the lesion. The image
was transformed into 20 optional colors according to the CT
oma. B, By using NIH image software, the HRCT image
CT numbers of each pixel. The GGO percentage was
area.arcin
the
GGOnumbers of each pixel within the lesion (Figure 1). In this study
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the intrapulmonary vascular structure. After the circumference of
the lesion was traced, the GGO percentage within the lesion was
calculated by tracing the colors corresponding to the GGO area.
On the basis of the GGO percentage, all the tumors were classified
into 4 categories: those with GGO percentages of 90% to 100%
(type I), 50% to 89% (type II), 10% to 49% (type III), and 0% to
9% (type IV).
Statistical Analysis
Data were analyzed by using the Student unpaired t test and the 2
test. Survival time was calculated from the date of the operation.
Cumulative survival rates were calculated by using the Kaplan-
Meier method and analyzed with the log-rank test. A multivariate
analysis was carried out by using the Cox proportional hazards
regression model.
Results
Of 146 patients, 23 had type I tumors, 45 had type II tumors,
33 had type III tumors, and 45 had type IV tumors. Patient
characteristics of each group are shown in Table 1. The
patients with type IV tumors included a significantly larger
number of male subjects and smokers than the patients with
type I/II tumors (P  .025). The mean tumor size of type
I/II tumors was significantly smaller than that of type III/IV
tumors (type I vs type III/IV, P  .0001; type II vs type III,
P  .0038; type II vs type IV, P  .0006). The histologic
diagnoses of each group are shown in Table 2. BAC ac-
counted for the majority of type I tumors (20/23 [87.0%]),
whereas adenocarcinoma accounted for 55.6% (25/45) of
type II and 90.9% (30/33) of type III tumors. All the lesions
of squamous cell carcinoma and large cell carcinoma were
included in type IV.
Wedge resection was performed in 15 patients with type
I, 14 with type II, 3 with type III, and 4 with type IV tumors.
Of those, 10 patients with type I and 12 with type II tumors
who were given diagnoses of a pure GGO appearance by
means of the macroscopic evaluation of HRCT images
underwent intentional wedge resection according to our
prospective study since June 2000. Segmentectomy was
TABLE 1. Patient characteristics
Type I
(n  23)
Type II
(n  45)
Type III
(n  33)
Type IV
(n  45)
Sex (male/female) 8/15 18/27 14/19 28/17
Smoking (/) 5/18 15/30 17/16 28/17
Age (y) 63.1 8.2 62.6 10.6 62.6 9.6 69.7 8.3
Tumor size (mm) 12.0 6.4 16.7 6.4 21.0 6.1 21.7 6.7
Resection
Lobectomy 7 28 29 39
Segmentectomy 1 3 1 2
Wedge 15 14 3 4performed in 1 patient with type I, 3 with type II, 1 with
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who underwent lymph node dissection or sampling for type
I/II tumors had no nodal involvement, whereas lymph node
metastases were identified in 20.0% (6/30) of patients with
type III and 24.4% (10/41) of patients with type IV tumors
(type I/II vs type III, P  .0008; type I/II vs type IV, P 
.0001). Of those with lymph node involvement, 4 patients
with type III tumors (13.3% [4/30]) and 6 patients with type
IV tumors (14.6% [6/41]) had N2 disease. None of the
patients with type I/II tumors showed vessel infiltration,
except 1 patient, whose GGO ratio was 50.0%, whereas
36.4% (12/33) of patients with type III tumors and 75.6%
(34/45) of patients with type IV tumors had vascular inva-
sion (P  .0001).
At the median follow-up period of 24.5 months, 3 pa-
tients had died. Two patients with type IV tumors died from
tumor progression, and one with a type III tumor died of
cerebral infarction, although there was no recurrence of the
tumor. The 3-year overall survival of all patients was
97.5%. The 3-year disease-free survival was 97.7% for
patients with type I/II tumors (n  68), 86.1% for patients
with type III tumors (n  33), and 78.5% for patients with
type IV tumors (n  45; Figure 2). Patients with type IV
tumors showed a significantly poorer disease-free survival
than patients with type I/II tumors (P  .025). All the
patients with type I tumors were alive without any recur-
rences, whereas one patient with a type II tumor who
underwent wedge resection because of a poor pulmonary
reserve for a tumor with a GGO ratio of 50.0% had a relapse
at the surgical margin.
Univariate analyses of disease-free survivals by several
TABLE 2. Histopathologic findings
Type I
(n  23)
Type II
(n  45)
Type III
(n  33)
Type IV
(n  45)
Histologic subtype
BAC 20 20 3 1
w/d adenocarcinoma 3 22 20 4
m/d adenocarcinoma 0 2 9 18
p/d adenocarcinoma 0 1 1 7
Squamous cell
carcinoma
0 0 0 13
Large cell carcinoma 0 0 0 2
pN status
N0 8 31 24 31
N1 0 0 2 4
N2 0 0 4 6
NX 15 14 3 4
Vessel infiltration
Negative 23 44 21 11
Positive 0 1 12 34
BAC, Bronchioloalveolar carcinoma; w/d, well-differentiated; m/d, moder-
ately differentiated; p/d, poorly differentiated.prognostic factors, including sex, smoking history, tumor
e 2005
Nakata et al General Thoracic Surgery
G
TSsize, and the GGO percentage, are summarized in Table 3.
There was a significant difference in the disease-free sur-
vival between the patients with a GGO ratio of 50% or
greater and those with a GGO ratio of less than 50%,
whereas no significant differences were found in other vari-
ables. The multivariate analysis also demonstrated that the
GGO percentage calculated with NIH image software was a
significant predictor of a favorable disease-free survival
(Table 4).
Discussion
In 1995, the Lung Cancer Study Group reported a higher
incidence of locoregional recurrence after limited resec-
tion for T1 N0 lung cancer compared with that after
lobectomy.13 On the basis of the results, lobectomy with
systemic mediastinal lymphadenectomy is considered the
standard treatment for patients with early-stage NSCLC.
However, with the increasing detection of peripheral
small lung cancer, there is a growing need for an ade-
quate treatment strategy for small NSCLC. Several stud-
ies have demonstrated various predictive factors of pe-
ripheral small adenocarcinoma, which accounted for the
majority of CT-detected lung cancers. Higashiyama and
associates14 found an excellent prognosis of the tumor
consisting of a BAC component of 100% when compared
with that of tumors with a lesser BAC component. Suzuki
and coworkers15 reported a 100% survival in patients
TABLE 3. Univariate analyses of prognostic factors
Variables Unfavorable Favorable P value
Sex Male Female .079
Smoking history Yes No .218
Tumor size  15 mm  15
mm
.212
GGO percentage  50%  50% .010GGO, Ground-glass opacity.
The Journal of Thoracicwith adenocarcinomas with a central fibrosis of 5 mm or
smaller. Although these results are useful to predict a
good prognosis, candidates for curative limited pulmo-
nary resection cannot be selected on the basis of these
prognostic factors because the quantitative analyses for
the predictive values are possible only by means of
postoperative pathologic examination but not preopera-
tively. Kodama and colleagues7 studied the relevance of
radiologic findings of small adenocarcinoma to patho-
logic studies and demonstrated that a GGO ratio of
greater than 50% on HRCT images was a preoperative
indicator of a favorable outcome. Matsuguma and asso-
ciates16 also reported that the adenocarcinoma with a
higher proportion of GGO area (50%) had neither
lymph node metastasis nor lymphatic invasion. This
novel radiologic classification provided an insight into
the possibility of selecting an adequate candidate for
curative limited resection for small peripheral adenocar-
cinoma. However, there still remain some controversies
to be determined. Of these, one of the essential problems
concerns the limited objectivity in the radiologic evalu-
ation of the GGO ratio. The macroscopic measurement of
the GGO ratio on HRCT images is so subjective that
individual variations can easily occur, and any overesti-
mation could increase the risk of local recurrence and
poor outcome after limited pulmonary resection. A few
attempts were already made at an objective radiologic
analysis for small adenocarcinoma. Nomori and cowork-
TABLE 4. Multivariate analyses of prognostic factors
Variables Risk ratio 95% CI P value
Sex 2.57 0.82-6.71 .120
Smoking history 1.52 0.14-1.78 .412
Tumor size 1.74 0.15-3.57 .735
GGO percentage 1.11 0.98-1.30 .056
Figure 2. The disease-free survival curves for
patients with small peripheral NSCLC ac-
cording to the GGO percentage of the lesion.
The 3-year disease-free survival rate was
97.7% for patients with type I and type II
tumors (n  68), 86.1% for patients with type
III tumors (n  33), and 78.5% for patients
with type IV tumors (n  45).CI, Confidence interval; GGO, ground-glass opacity.
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CT numbers. Matsuguma and colleagues18 showed the
validity of measurement of GGO ratio with Scion Image
(Scion Corporation, Frederick, Md). In this study we
used NIH image software for an objective radiologic
evaluation of the GGO ratio to select the appropriate
candidates for limited resection. NIH image software is
freely available from the respective Web site. We think
that studying the validity of widespread basic software is
useful for future trials and clinical practice.
The recognition of the GGO area becomes easy and
objective by means of analysis with NIH image software
because the CT numbers of each pixel are expressed by
20 optional colors. The classification on the basis of the
GGO percentage calculated with NIH image software
exhibited a good correlation with the histologic classifi-
cation, pathologic invasiveness, and postoperative out-
come. Eighty-seven percent of type I tumors (GGO of
90%-100%) were diagnosed as being noninvasive BAC,
and no vessel infiltrations were identified in all 23 le-
sions. All the patients with type I tumors were alive
without any recurrences to date. Type I tumors corre-
sponded to the lesions described as pure GGO in the
previous reports. Our current study verified the reports
that demonstrated a good prognosis of pure GGO.19-22
Fifty-five percent of type II tumors (GGO of 50%-89%)
constituted adenocarcinoma, whereas there was no lymph
node involvement in 31 patients who underwent node
sampling or dissection, and no vascular invasion was
identified in any of the 45 lesions, except for in 1 lesion
with a GGO of 50%. On the contrary, 22.5% (16/71) of
patients with type III and IV tumors revealed lymph node
metastases regardless of the tumor size, and patients with
type IV tumors showed a significantly poorer disease-free
survival than patients with type I and II tumors. These
results showed that it was the most appropriate for se-
lecting treatment strategies to classify peripheral small
lung cancers into 3 categories on the basis of GGO ratios
of 90% to 100%, 50% to 89%, and 0% to 49%. Patients
with tumors having GGO ratios of 90% to 100% can be
considered as the most appropriate target for limited
resection because the great majority of the tumors in this
category are noninvasive. In these cases even observation
without any surgical intervention would be one of the
choices because BAC was reported to have a tumor
doubling time of more than 1 year.23 Tumors with GGO
ratios of less than 50% have invasive features, and lymph
node involvement was not uncommon. It has been shown
that 10% to 20% of lung cancers of 2 cm or less in size
have lymph node metastasis,24,25 and our results of pa-
tients with type III or IV tumors were comparable with
the data. Standard anatomic resection with systemic me-
diastinal lymph node dissection is inevitable, even for a
1230 The Journal of Thoracic and Cardiovascular Surgery ● Junsmall lung cancer with a GGO ratio of less than 50%. On
the other hand, tumors with GGO ratios of 50% to 89%
comprise the most heterogeneous group. Although the
majority of tumors in this category were pathologically
diagnosed as invasive adenocarcinoma, the minimal vas-
cular infiltration and negative lymph node metastases in
our series suggested that patients with tumors with GGO
ratios of 50% to 89% could also be candidates for cura-
tive limited pulmonary resection, such as segmentectomy
or even regional wedge resection. Further randomized
studies are warranted to confirm the hypothesis obtained
from our small series. However, we believe that an equiv-
alent prognosis after limited resection could be expected
by strict patient selection on the basis of an objective
quantitative radiologic analysis.
When designing a prospective study, it is critically im-
portant to decide the threshold of the GGO percentage for
assigning the patient to limited surgical intervention. Previ-
ous reports on the basis of the macroscopic estimations
suggested that GGO ratios of greater than 50% were re-
quired for a patient to qualify as a candidate for limited
resection. It should be noted that the similar results were
obtained in our study on the basis of the objective radiologic
analysis. However, even in our small series, one patient with
a GGO ratio of 50% exhibited vessel infiltrations and ex-
perienced local recurrence after wedge resection. The limit
of the GGO percentage for assignment to limited surgical
intervention should be more than 50%, for instance 60% or
70%, to guarantee the ethics and safety of a prospective
study. When such strict criteria are required to select the
eligible patients, a subjective macroscopic evaluation is
useless, and the lack of a method of objective quantitative
radiologic analyses has prevented a large-scale multicenter
trial. We believe that NIH image software will play an
important role for selecting the eligible patients for the
future clinical trials, as well as for deciding the treatment
strategy at clinical practice.
In conclusion, appropriate patients for limited resection
could be selected on the basis of the objective radiologic
evaluation. Radiologic analysis with NIH image software
exhibited a good correlation with the histologic classifica-
tion, pathologic invasiveness, and postoperative outcome of
small peripheral lung cancer. Patients with tumors having
GGO ratios of larger than 50% are considered to be possible
candidates for limited pulmonary resection. Further studies
should be encouraged, with strict criteria on the basis of an
objective quantitative radiologic evaluation.
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